Cordis Names George Adams, MD as Chief Medical Officer
PR93572
MIAMI LAKES, Fla., Dec. 10, 2021 /PRNewswire=KYODO JBN/ --
-- Globally recognized interventional cardiologist is the latest addition to a
growing leadership team
Cordis, a global cardiovascular technology company, today announced George
Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the
organization's mission to differentiate itself as a technological leader and
value-based global medical device company.
Photo - https://mma.prnewswire.com/media/1704164/NewPictureGeorgeAdamsMD.jpg
Logo - https://mma.prnewswire.com/media/1703651/Cordis_logo_R___jpeg_Logo.jpg
"We are delighted to have Dr. Adams join our team as we continue to build the
new Cordis," said CEO Shar Matin. "His depth of expertise in the treatment of
both complex coronary and peripheral vascular disease will play a vital role in
furthering our mission to improve patient care at pace with cost-effective,
differentiated solutions that build on our legacy of innovation."
Dr. Adams comes to Cordis with a distinguished combination of clinical
practice, medical research, and product development experience. He is globally
recognized for his expertise in the treatment of peripheral vascular disease in
patients with critical limb ischemia (CLI) and treatment of coronary artery
disease in patients with acute coronary syndromes. He is involved in the
development of regional and national systems of care for the treatment of CLI,
ST-Elevation Myocardial Infarction (STEMI), and management of complex coronary
and peripheral vascular disease. He has a well-established network of peers and
associates who are viewed as key opinion leaders within the global
cardiovascular community.
Dr. Adams plays an integral role in global peer education. He strives to
advance the field of medicine through leadership and moderation of, as well as
participation in, numerous cardiovascular and peripheral vascular forums
spanning national and global platforms.
He is a sought-after speaker and well-published researcher, serving as primary
investigator for multiple clinical trials. He is certified by The American
Board of Internal Medicine in internal medicine and cardiovascular disease.
"It is with great honor and excitement that I join the Cordis team as Chief
Medical Officer," said Dr. Adams. "I look forward to playing a role in
reinvigorating an incredible 62-year legacy. I am grateful to be a part of the
future that Cordis is building with integrity and a vision for innovation."
About Cordis
Cordis is a worldwide leader in the development and manufacturing of
interventional cardiovascular technologies with a more than 60-year history of
pioneering breakthrough therapies to treat millions of patients. With a
reputation for clinical acumen, training, and services, Cordis established a
legacy of innovation in high-quality and minimally invasive cardiovascular
products and built a strong global footprint with operations in more than 60
countries around the world.
Contact:
Kurt Haggstrom, Vice President, Global Marketing
Phone: 949-244-7382
Email: kurt.haggstrom@cardinalhealth.com
SOURCE: Cordis
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。